HiFi DNA Tech has sued the US Food and Drug Administration for allegedly failing to respond in time to a petition to down-classify its PCR-based human papillomavirus genotyping test, leading the company to claim that the agency’s regulatory approach is out of step with current scientific thinking about the link between HPV and cervical cancer.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.